NIAID-Supported Phase 1 Trial of Potential Broadly Protective Vaccine September 17, 2018 An early-stage clinical trial testing the safety and immune-stimulating ability of an experimental nasal influenza vaccine in healthy… read more →
FLUGEN BEGINS ENROLLMENT OF CLINICAL TRIAL OF NOVEL INVESTIGATIONAL INFLUENZA VACCINE AGAINST MULTI-SEASON MISMATCHED STRAINS —Investigational vaccine designed to generate broad and durable immune protection over multiple influenza seasons— —Subjects… read more →
VIRUS PROTECTION | EUROPEAN STUDY PLANNED JUDY NEWMAN jdnewman@madison.com FluGen, a Madison company developing a universal influenza vaccine, is gearing up for a new round of studies on human volunteers… read more →
January 17, 2018 By David Tenenbaum For news media Amid predictions that this year’s flu vaccine will offer limited protection, medical researchers are renewing their focus on a universal flu… read more →